2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Solvents: new trials by email Literature Review of Solvents trials Research Report on Solvents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19), Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%) - Covid19 | Phase 1 / Phase 2 | Completed | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 100 | 2020-07-27 | 2022-03-16 |
| Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. - Cystic Fibrosis | Phase 1 | Completed | Neupharma Srl | 12 | 2019-10-25 | 2020-12-09 |
COVID-19 (1) · Cystic Fibrosis (1)
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" (1) · Neupharma Srl (1)
Italy (1) · Russia (1)
Giulia Paiola, MD (1) · Vladimir I. Kuzubov (1)